Friday, July 31, 2026
In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a Florida man's lawsuit against OpenAI after ChatGPT repeatedly dismissed his pulmonary embolism symptoms as "not something dangerous." The case raises urgent questions about AI medical liability just as a new JAMA analysis reveals updated cholesterol guidelines now make 87.5 million US adults eligible for statins (more than 56% of the 30-to-79 population). Plus: they also discuss the FDA's first dual-ingredient OTC pain reliever, Lego MRI models cutting pediatric sedation rates by nearly half, and Europe's approval of a retinal implant that helped 84% of participants read again. Plus: oral GLP-1 competition heats up and a new smell-impairment and depression link.
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production